Concepedia

Febri Wulandari

FW

Statistics

Publications

8

Citations

144

H-Index

8

Active since

2020

Affiliations

Universitas Gadjah Mada(Current)

Nara Institute of Science and Technology

Institute of Macromolecular Chemistry

Osaka Prefecture University

Febri Wulandari is an author at Universitas Gadjah Mada specializing in cancer pharmacology, pharmacology, and medicine.

ORCID

Publications per year

2020–2022

8

Publications

8

Piperine Increases Pentagamavunon-1 Anti-cancer Activity on 4T1 Breast Cancer Through Mitotic Catastrophe Mechanism and Senescence with Sharing Targeting on Mitotic Regulatory Proteins

Endah Endah, Febri Wulandari, Yurananda Putri et al. · Iranian journal of pharmaceutical research · 2022 · 25 citations · Full text

, , +15

The Growth Suppression Activity of Diosmin and PGV-1 Co-Treatment on 4T1 Breast Cancer Targets Mitotic Regulatory Proteins

Hajidah Musyayyadah, Febri Wulandari, Ana Fiin Nangimi et al. · Asian Pacific Journal of Cancer Prevention · 2021 · 21 citations · Full text

, , +17

Curcumin-like structure (CCA-1.1) induces permanent mitotic arrest (Senescence) on Triple-negative breast cancer (TNBC) cells, 4T1

Dhania Novitasari, Riris Istighfari Jenie, Febri Wulandari et al. · Research Journal of Pharmacy and Technology · 2021 · 20 citations

, , +14

Preparation and Cytotoxic Evaluation of PGV-1 Derivative, CCA-1.1, as a New Curcumin Analog with Improved-Physicochemical and Pharmacological Properties

Rohmad Yudi Utomo, Febri Wulandari, Dhania Novitasari et al. · Advanced Pharmaceutical Bulletin · 2021 · 19 citations · Full text

, , +15

Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study

Adam Hermawan, Febri Wulandari, Naufa Hanif et al. · Scientific Reports · 2022 · 17 citations · Full text

, , +14

1–5 of 8